Co-Occurring Medical Disorders

Co-Occurring Medical Disorders

Recorded: Thursday, September 29, 2022 - Saturday, October 1, 2022
On-Demand Session

Overview

This 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course discusses research and treatment approaches for common co-occurring medical disorders, such as HCV, Drug Use-Associated Infective Endocarditis (DUA-IE), liver disease, and Skin and Soft Tissue Infections (SSTIs).
Patients receiving addiction treatment frequently present with medical and psychological conditions that can greatly affect their overall well-being. This 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course discusses research and treatment approaches for common co-occurring medical disorders, such as HCV, Drug Use-Associated Infective Endocarditis (DUA-IE), liver disease, and Skin and Soft Tissue Infections (SSTIs). Following each presentation, presenters answer audience questions.

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• Removing "Alcoholic" from Alcohol Related Liver Disease
  Alcohol related liver disease and its consequences are on the rise. Identification of unhealthy alcohol use along with the provision of evidenced-based treatment can improve overall liver health. In this session, we will discuss alcohol related liver disease, its management, including the use of early liver transplant, and the importance of integrating care for alcohol use concurrently with treatment for liver disease. We will also discuss the importance of identifying and reducing stigma associated with alcohol related liver disease.
• Shifting the Treatment Paradigm for Endocarditis Among People Who Use Drugs: Treat the Person, Not Just the Infection
  Drug use-associated IE (DUA-IE) now accounts for 1 in 10 hospitalizations endocarditis with an inpatient mortality rate between 5-8% and up to 26% in the year following discharge. At this rate, nearly 300,000 Americans will die of DUE-IE between 2020 and 2030. There is an urgent need to address the growing burden of DUA-IE in the U.S. To do so, providers must shift the treatment paradigm from a "do as I say" approach to a patient-focused "what do you need?" approach. Individuals with DUA-IE require more than just intravenous antibiotics. In this session, we will explore treatment paradigms that treat the person, not just the infection, to improve clinical outcomes and quality of life.
• One Size Does Not Fit All: HCV Care in Various Settings
  Hepatitis C virus (HCV) infection is the leading cause of infectious disease death in the US. Despite the availability of effective oral direct acting agents (DAA) of short duration (2-3months) which have minimal side effects and cure HCV in over 95% of people who take these medications, treatment uptake among people who use drugs remains low. This session will review the current simplified approach to HCV screening and treatment as a prelude to a discussion of barriers to HCV treatment uptake among people who use drugs and strategies with proven effectiveness to increase HCV treatment uptake. These strategies will focus on integrated care, low threshold and peer supported approaches
• Meeting People Where They are: Integrating Wound Care with Addiction Services
  In this talk we will review the impact of and risk factors for skin and soft tissue infections (SSTIs) among people who inject drugs (PWID), as well as barriers to healthcare and benefits of integrating wound care into addiction services. We will describe a model of integrated street medicine services for people who use drugs located in Baltimore, and successes and challenges with providing wound care in this model. We will review basic clinical wound care for PWID, with a focus on outpatient care and counseling for patients in SSTI prevention and wound care.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 10/1/2025

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

CME, CE, CEU and Other Credit Types

ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The American Society of Addiction Medicine designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1222

Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification (MOC) / Continuing Certification Program (CCP)

The ASAM State of the Art Course  meets the CME requirements for the following primary boards:
• American Board of Medical Specialties (ABMS)
• American Board of Preventive Medicine (ABPM)
• American Board of Anesthesiology (ABA)
• American Board of Pediatrics (ABP)
• American Board of Internal Medicine (ABIM)
• American Board of Surgery (ABS)
• American Board of Psychiatry and Neurology (ABPN)
• American Board of Addiction Medicine (ABAM)
• Royal College of Physicians and Surgeons of Canada (RCPSC

Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.